NFE2L2 and Parkinson disease: Furthermore, the Nrf2 pathway activates CMA, inhibits α-synuclein accumulation, and alleviates rotenone-induced DAergic neuron degeneration, suggesting that the Nrf2 pathway orchestrates CMA, thereby alleviating neurodegeneration in PD [40].